Navigation Links
Intravenous Immune Biologics Will Suffer from the Pending Shift in Coverage from the Medical to the Pharmacy Benefit
Date:7/15/2009

NASHVILLE, Tenn. and GLEN ROCK, N.J., July 15 /PRNewswire/ -- HealthLeaders-InterStudy and Fingertip Formulary find that surveyed pharmacy directors of both national and single state plans say coverage of immune biologics will shift from a medical benefit to a pharmacy benefit by 2014, citing Centocor Ortho Biotech's Remicade and UCB's Cimzia among products that will be most affected by this shift. According to the new Formulary Forum report entitled Formulary Advantages in Immune Biologics: Tightening Payer Control Offers Opportunities for Differentiation, the majority of surveyed pharmacy directors say they currently cover Amgen/Wyeth's Enbrel and Abbott's Humira solely as a pharmacy benefit, but cover other immune biologics as a medical benefit.

The report finds that payers expect the shift of biologics from the medical benefit to the pharmacy benefit is motivated by an expectation of increased cost control. For example, 34 percent of surveyed payers currently require patients taking an IV biologic to first fail therapy with an SC biologic and will continue to enforce this requirement moving forward. An additional 38 percent of surveyed payers expect to newly implement this cost control measure over the next five years.

"Managed care organizations are looking to restrict patient access to physician-administered biologics, because these agents are harder to control in terms of cost outlays--in part due to physicians preferentially prescribing agents such as Remicade so the physician can purchase the agent at a discount relative to the reimbursement rate and thus maintain a profit margin on the procedure," said Michael Malecki, Ph.D., product manager for Formulary Forum. "Maintaining control of the supply chain will be critical to the future profitability of managed care organizations, and plans are aware of this fact. By 2014, for example, 84 percent of surveyed pharmacy dire
'/>"/>

SOURCE HealthLeaders-InterStudy
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. FDA Clears MDN-CGS(R) Intravenous Insulin Dosing Software
2. BioCryst Reports Positive Results From a Phase 2 Study of Intravenous Peramivir for Outpatient Influenza
3. Most Important Factors Driving Usage of Antibiotics in the ICU Setting are Availability in Intravenous Formulation, Activity Against Key Gram Negative Pathogens, Drug Interactions and Bactericidal Activity
4. New form of intravenous iron treats anemia in chronic kidney disease patients on dialysis
5. Number of cardiovascular risk factors could determine safety of intravenous gammaglobulin treatment
6. New Bill Offers Medicare Reimbursement Fix for Intravenous Immune Globulin
7. Availability in Both Intravenous and Oral Formulation is a Leading Drug Attribute Surveyed Physicians Prefer for the Treatment of Urinary Tract Infections in the Hospital Setting
8. Penn study finds pro-death proteins required to regulate healthy immune function
9. Immune deficiency linked to a type of eye cancer
10. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
11. Melanoma drug revs immune cells but cancer cells ignore it
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... A program for anyone looking to ... University of Colorado Anschutz Health and Wellness Center ... camp and transformation program. , “Extreme Weight Loss: ... USA, is an evidenced-based program inspired by the unscripted ... USA. This season, the show has participants spending their ...
(Date:7/31/2014)... CA (PRWEB) July 31, 2014 Dr. ... closure in front of an enthusiastic audience of international ... Trichophytic Closure improves the appearance of a patient’s ... results of this procedure are minimally detectable in most ... technique improves on the original method of donor wound ...
(Date:7/31/2014)... July 31, 2014 You’re having a wonderful ... have you suddenly developed chills and fever, headache, stiff neck, ... suspect a flu-like illness, it could actually be the first ... risk of developing Lyme is greater than you might think. ... cases occurred in the U.S. annually. But the Centers for ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 According to ... Business Journal , Endo International, one of several manufacturing ... thousands of transvaginal claims for $830 million (in re: ... Litigation (MDL No. 2325). Melinda Helbock, Founder of The ... agrees with the settlement and is pleased to see ...
(Date:7/31/2014)... LDM Global ( http://www.ldmglobal.com ) announces ... is simplified and predictable with fixed fees across the ... leading international provider of legal discovery management services for ... glaringly apparent that both the courts and legal counsel ... the complex pricing structure that plagues the litigation support ...
Breaking Medicine News(10 mins):Health News:"Extreme Weight Loss: Destination Boot Camp" Comes to Colorado - The CU Anschutz Health and Wellness Center Begins Transformational Program 2Health News:"Extreme Weight Loss: Destination Boot Camp" Comes to Colorado - The CU Anschutz Health and Wellness Center Begins Transformational Program 3Health News:Novel Technique in Wound Closure Delivers More Discreet Results in Hair Transplant Patients 2Health News:Feel Like You Have A Summertime 'Flu'? It Could Be Lyme Disease 2Health News:Feel Like You Have A Summertime 'Flu'? It Could Be Lyme Disease 3Health News:San Diego Product Liability Firm Provides Commentary on the Latest Developments in Transvaginal Mesh Litigation 2Health News:LDM Global Announces Predictable Simple Fixed-Fee Pricing 2
... Medical Manager and Misys Customers Get Discount to Switch ... ... 2008 -- CollaborateMD, a leading provider of Internet practice management ... industry, announced today an upgrade program for existing users of ...
... Calif., Aug. 13 Watson,Pharmaceuticals, Inc. (NYSE: ... that the United States District Court for the,Southern ... Sodium ER,tablets, the generic version of Naprelan(R), infringes ... action, Elan Corporation Plc v.,Andrx Pharmaceuticals, Inc., was ...
... Things are getting even rosier for,MGM Consumer ... that actress Emmy Rossum has signed on as ... as,Bulma in the upcoming feature film "Dragonball," and ... daughter), "The Phantom of the Opera" (as,Christine) and ...
... donations for breast cancer,research/programs, DETROIT, Aug. 13 ... part to end cancer, as well as honor the ... goal of walking 18,marathons in 18 days -- The ... cancer research and programs at the Barbara Ann Karmanos ...
... Olympics focuses attention on health problems outside the lungs, ... Air pollution has short-term and long-term toxic effects on ... cardiac illness, and even cause death, a new report ... in the Aug. 26 issue of the Journal ...
... Cutting-Edge Patient Safety ... ... with Kahala Nui, a Life Care Retirement Community in Honolulu,Hawai,i, to ... Care Center. Kahala Nui joins a list of,progressive healthcare facilities by ...
Cached Medicine News:Health News:CollaborateMD Offers Upgrade Program to Competitors' Users 2Health News:Watson Announces District Court Ruling in Naproxen Sodium Patent Suit 2Health News:Watson Announces District Court Ruling in Naproxen Sodium Patent Suit 3Health News:Actress Emmy Rossum to Act as Official Spokesperson of PiNKiTUDE, New Cause Marketing Initiative Inspired by MGM's Pink Panther, Benefits Susan G. Komen for the Cure(R) 2Health News:Actress Emmy Rossum to Act as Official Spokesperson of PiNKiTUDE, New Cause Marketing Initiative Inspired by MGM's Pink Panther, Benefits Susan G. Komen for the Cure(R) 3Health News:More Than 400-mile Victory Walk to Conclude Aug. 14, at Campus Martius 2Health News:More Than 400-mile Victory Walk to Conclude Aug. 14, at Campus Martius 3Health News:Air Pollution Can Damage Heart, Blood Vessels, Too 2Health News:Hoana Medical, Inc. Partners With Kahala Nui to Improve Patient Safety 2Health News:Hoana Medical, Inc. Partners With Kahala Nui to Improve Patient Safety 3Health News:Hoana Medical, Inc. Partners With Kahala Nui to Improve Patient Safety 4
(Date:7/31/2014)... , July 31, 2014 For its ... California , Art,s-Way Scientific has earned a ... With competition in over 30 categories, MBI,s contest ... MBI members, which include building manufacturers, dealers, and product ... an excellent example the capability of our team," said ...
(Date:7/31/2014)... LONDON , July 31, 2014 ... for the medical industries, announced today the incorporation of genae UK ... United Kingdom has one of the largest medical device ... in 2012 and it is projected to increase by a CAGR ... billion in 2012, equal to 9.5% of GDP. Despite recessionary pressures, ...
(Date:7/31/2014)... NEW YORK , July 31, 2014 /PRNewswire-USNewswire/ ... of discovering and developing better, faster and affordable ... as Senior Vice President, External Affairs. Mr. ... served as Head of Major Donor Relations for ... Fund). In his role, Mr. Brock will guide ...
Breaking Medicine Technology:Art's Way Scientific Earns Prestigious Modular Building Institute Award 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 3Art's Way Scientific Earns Prestigious Modular Building Institute Award 4genae Opens Offices in London 2TB Alliance Appoints Willo Brock Senior Vice President, External Affairs 2
... 15 The U.S. Food and Drug Administration (FDA), ... Justice (USDOJ), today announced that Forest Pharmaceuticals, Inc. entered ... responsibility for criminal actions including distribution of an unapproved ... of an FDA inspection. (Logo:   ...
... 15 New England Biolabs (NEB) has announced ... of $1.22 million to fund the research and ... (Logo: http://photos.prnewswire.com/prnh/20090921/NE79207LOGO-b) (Logo: http://www.newscom.com/cgi-bin/prnh/20090921/NE79207LOGO-b) ... developing tools that advance epigenetics research and discovery, ...
Cached Medicine Technology:Forest Pharmaceuticals Agrees to Guilty Plea for Violating FDA Laws 2Forest Pharmaceuticals Agrees to Guilty Plea for Violating FDA Laws 3New England Biolabs Receives Award to Develop Novel Enzymatic Reagents for Epigenetic Studies 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: